These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6204221)
41. Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats. Xu G; Jiang XD; Xu Y; Zhang J; Huang FH; Chen ZZ; Zhou DX; Shang JH; Zou YX; Cai YQ; Kou SB; Chen YZ; Xu RX; Zeng YJ Cell Biol Int; 2009 Apr; 33(4):466-74. PubMed ID: 18725309 [TBL] [Abstract][Full Text] [Related]
42. Comparison of cellular immunotherapies and anti-CD3 in the treatment of MCA-38-LD experimental hepatic metastases in C57BL/6 mice. Gallinger S; Hoskin DW; Mullen JB; Wong AH; Roder JC Cancer Res; 1990 Apr; 50(8):2476-80. PubMed ID: 2138507 [TBL] [Abstract][Full Text] [Related]
43. Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain. Tseng SH; Hsieh CL; Lin SM; Hwang LH Cancer Gene Ther; 1999; 6(4):302-12. PubMed ID: 10419048 [TBL] [Abstract][Full Text] [Related]
44. Treatment of primitive malignant tumors of the central nervous system. Clinical evaluation of 91 cases. Paoletti P; Baldini M; Knerich R; Princi L Acta Neurol (Napoli); 1979 Feb; 1(1):39-44. PubMed ID: 433679 [No Abstract] [Full Text] [Related]
45. Multimodality treatment of malignant gliomas. Comparison of several adjuvant approaches. Jellinger K; Volc D; Grisold W; Podreka I; Böck F; Schuster H; Alth G; Kogelnik HD Zentralbl Neurochir; 1981; 42(2-3):99-119. PubMed ID: 6267846 [No Abstract] [Full Text] [Related]
46. [Cloning of mouse glioma-specific killer T cells]. Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M Neurol Med Chir (Tokyo); 1983 Mar; 23(3):181-3. PubMed ID: 6193442 [No Abstract] [Full Text] [Related]
47. Cortical ependymoma or monomorphous angiocentric glioma? Lum DJ; Halliday W; Watson M; Smith A; Law A Neuropathology; 2008 Feb; 28(1):81-6. PubMed ID: 18021197 [TBL] [Abstract][Full Text] [Related]
48. [Interferon therapy for primary brain tumors (Part I). Local administration]. Nakagawa Y Neurol Med Chir (Tokyo); 1984 Feb; 24(2):83-9. PubMed ID: 6205292 [No Abstract] [Full Text] [Related]
49. Induction of specific T helper-9 cells to inhibit glioma cell growth. Zheng H; Yang B; Xu D; Wang W; Tan J; Sun L; Li Q; Sun L; Xia X Oncotarget; 2017 Jan; 8(3):4864-4874. PubMed ID: 28002799 [TBL] [Abstract][Full Text] [Related]
50. Antigen-receptor gene-modified T cells for treatment of glioma. Ikeda H; Shiku H Adv Exp Med Biol; 2012; 746():202-15. PubMed ID: 22639170 [TBL] [Abstract][Full Text] [Related]
51. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice. Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514 [TBL] [Abstract][Full Text] [Related]
53. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18. Yamanaka R; Xanthopoulos KG DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409 [TBL] [Abstract][Full Text] [Related]
54. The cellular immunotherapy of primary brain tumors. Hayes RL Rev Neurol (Paris); 1992; 148(6-7):454-66. PubMed ID: 1448666 [TBL] [Abstract][Full Text] [Related]
55. Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma. Saito R; Mizuno M; Nakahara N; Tsuno T; Kumabe T; Yoshimoto T; Yoshida J Int J Cancer; 2004 Sep; 111(5):777-82. PubMed ID: 15252850 [TBL] [Abstract][Full Text] [Related]
56. TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma. Nakagawa J; Saio M; Tamakawa N; Suwa T; Frey AB; Nonaka K; Umemura N; Imai H; Ouyang GF; Ohe N; Yano H; Yoshimura S; Iwama T; Takami T Int J Oncol; 2007 Apr; 30(4):803-11. PubMed ID: 17332918 [TBL] [Abstract][Full Text] [Related]
57. [Efficacy of experimental active specific immunotherapy and immunoprevention of malignant gliomas of the brain]. Romodanov SA; Zatula DG; Lisianyĭ NI; Glavatskiĭ AIa; Prosvirneva GM Zh Vopr Neirokhir Im N N Burdenko; 1986; (3):18-23. PubMed ID: 3739492 [TBL] [Abstract][Full Text] [Related]
58. [Malignant cerebral tumors in children]. Doz F Rev Prat; 1993 Nov; 43(17):2187-91. PubMed ID: 8146534 [TBL] [Abstract][Full Text] [Related]
59. Tumors of the central nervous system in children. Heideman RL Rocky Mt Med J; 1979; 77(3):27A-32A. PubMed ID: 462081 [No Abstract] [Full Text] [Related]
60. Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial. Jacobs SK; Wilson DJ; Kornblith PL; Grimm EA Cancer Res; 1986 Apr; 46(4 Pt 2):2101-4. PubMed ID: 3512079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]